Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Khalil Barrage currently holds 22,500 shares of Protagenic Therapeutics, Inc. ew (PTIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Khalil Barrage has been a net neutral trader of PTIX stock. They have purchased $0 and sold $0 worth of shares.
Khalil Barrage's most recent insider trade was on Mar 25, 2024, when they sold 22,500 shares at $1.74 per share.
Khalil Barrage serves as Executive at Protagenic Therapeutics, Inc. ew (PTIX). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Khalil Barrage holds the position of Executive at Protagenic Therapeutics, Inc. ew, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Khalil Barrage has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Khalil Barrage was on May 3, 2021, when they sold $210.0K worth of PTIX shares. This transaction involved 120,000 shares at $1.75 per share.
Khalil Barrage currently owns 22,500 shares of Protagenic Therapeutics, Inc. ew (PTIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Khalil Barrage's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Khalil Barrage has 7 Form 4 filings on record as an insider at Protagenic Therapeutics, Inc. ew.
Set alerts for Khalil Barrage and 40,000+ other insiders.